(Q28294060)

English

RETRACTED: Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications (a study from the Lunenburg Lymphoma Biomarker Consortium)

retracted scientific article

Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications (a study from the Lunenburg Lymphoma Biomarker Consortium)

In more languages

Statements

scholarly article

0 references

retracted paper

2 references

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

RETRACTED: Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications (a study from the Lunenburg Lymphoma Biomarker Consortium) (English)

0 references

0 references

immunohistochemistry

1 reference

based on heuristic

inferred from title

B-cell lymphoma

1 reference

based on heuristic

inferred from title

diffuse large B-cell lymphoma

1 reference

based on heuristic

inferred from title

Andreas Rosenwald

3

0 references

author name string

D de Jong

1

0 references

W Xie

2

0 references

M Chhanabhai

4

0 references

P Gaulard

5

0 references

W Klapper

6

0 references

A Lee

7

0 references

B Sander

8

0 references

C Thorns

9

0 references

E Campo

10

0 references

T Molina

11

0 references

A Hagenbeek

12

0 references

S Horning

13

0 references

A Lister

14

0 references

J Raemaekers

15

0 references

G Salles

16

0 references

R D Gascoyne

17

0 references

E Weller

18

0 references

language of work or name

0 references

publication date

February 2009

0 references

Journal of Clinical Pathology

0 references

62

0 references

2

0 references

128-38

0 references

is retracted by

0 references

BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1136/JCP.2008.057257

Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1136/JCP.2008.057257

Prognostic significance of Bcl-6 protein expression in DLBCL treated with CHOP or R-CHOP: a prospective correlative study

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1136/JCP.2008.057257

Forkhead box protein P1 expression in mucosa-associated lymphoid tissue lymphomas predicts poor prognosis and transformation to diffuse large B-cell lymphoma

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1136/JCP.2008.057257

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1136/JCP.2008.057257

Validation of tissue microarray immunohistochemistry staining and interpretation in diffuse large B-cell lymphoma

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1136/JCP.2008.057257

Cell of origin, germinal center versus nongerminal center, determined by immunohistochemistry on tissue microarray, does not correlate with outcome in patients with relapsed and refractory DLBCL.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1136/JCP.2008.057257

Diffuse large B-cell lymphoma in pediatric patients belongs predominantly to the germinal-center type B-cell lymphomas: a clinicopathologic analysis of cases included in the German BFM (Berlin-Frankfurt-Munster) Multicenter Trial

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1136/JCP.2008.057257

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1136/JCP.2008.057257

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1136/JCP.2008.057257

Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1136/JCP.2008.057257

Germinal center phenotype and bcl-2 expression combined with the International Prognostic Index improves patient risk stratification in diffuse large B-cell lymphoma

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1136/JCP.2008.057257

Strong expression of FOXP1 identifies a distinct subset of diffuse large B-cell lymphoma (DLBCL) patients with poor outcome

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1136/JCP.2008.057257

BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1136/JCP.2008.057257

Clinical significance of bcl2 and p53 protein expression in diffuse large B-cell lymphoma: a population-based study.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1136/JCP.2008.057257

Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1136/JCP.2008.057257

Rituximab plus CHOP (R-CHOP) overcomes bcl-2--associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL).

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1136/JCP.2008.057257

Prognostic impact of germinal center-associated proteins and chromosomal breakpoints in poor-risk diffuse large B-cell lymphoma.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1136/JCP.2008.057257

HER2 testing by local, central, and reference laboratories in specimens from the North Central Cancer Treatment Group N9831 intergroup adjuvant trial

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1136/JCP.2008.057257

Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1136/JCP.2008.057257

Large cleaved and immunoblastic lymphoma may represent two distinct clinicopathologic entities within the group of diffuse large B-cell lymphomas.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1136/JCP.2008.057257

NFkappaB activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1136/JCP.2008.057257

Immunohistochemical expression patterns of germinal center and activation B-cell markers correlate with prognosis in diffuse large B-cell lymphoma.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1136/JCP.2008.057257

Identifiers

10.1136/JCP.2008.057257

0 references

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28294060&oldid=2041862407"